Follow
Sunali Mehta
Title
Cited by
Cited by
Year
Predictive and prognostic molecular markers for cancer medicine
S Mehta, A Shelling, A Muthukaruppan, A Lasham, C Blenkiron, G Laking, ...
Therapeutic advances in medical oncology 2 (2), 125-148, 2010
2502010
Susceptibility to chronic inflammation: an update
NA Nasef, S Mehta, LR Ferguson
Archives of Toxicology 91, 1131-1141, 2017
932017
133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
H Campbell, N Fleming, I Roth, S Mehta, A Wiles, G Williams, C Vennin, ...
Nature Communications 9 (1), 254, 2018
612018
Selective treatment of hypoxic tumor cells in vivo: phosphate pre‐prodrugs of nitro analogues of the duocarmycins
M Tercel, GJ Atwell, S Yang, A Ashoorzadeh, RJ Stevenson, KJ Botting, ...
Angewandte Chemie 123 (11), 2654-2657, 2011
532011
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
M Kazantseva, S Mehta, RA Eiholzer, G Gimenez, S Bowie, H Campbell, ...
Cell death & disease 10 (9), 631, 2019
432019
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
M Kazantseva, RA Eiholzer, S Mehta, A Taha, S Bowie, I Roth, J Zhou, ...
The Journal of pathology 246 (1), 77-88, 2018
392018
Expression and role in glycolysis of human ADP-dependent glucokinase
S Richter, JP Richter, SY Mehta, AM Gribble, AJ Sutherland-Smith, ...
Molecular and cellular biochemistry 364, 131-145, 2012
392012
A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology
S Mehta, P Tsai, A Lasham, H Campbell, R Reddel, A Braithwaite, C Print
Cancer Research 76 (24), 7151-7159, 2016
372016
A novel EGR‐1 dependent mechanism for YB‐1 modulation of paclitaxel response in a triple negative breast cancer cell line
A Lasham, SY Mehta, SJ Fitzgerald, AG Woolley, JI Hearn, DG Hurley, ...
International journal of cancer 139 (5), 1157-1170, 2016
372016
Why be one protein when you can affect many? The multiple roles of YB-1 in lung cancer and mesothelioma
TG Johnson, K Schelch, S Mehta, A Burgess, G Reid
Frontiers in cell and developmental biology 7, 221, 2019
302019
Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case
N Ahmed Nasef, S Mehta, LR Ferguson
Frontiers in Genetics 5, 64, 2014
272014
Influence of a basic side chain on the properties of hypoxia-selective nitro analogues of the duocarmycins: Demonstration of substantial anticancer activity in combination with …
M Tercel, HH Lee, SY Mehta, JJ Youte Tendoung, SY Bai, HDS Liyanage, ...
Journal of Medicinal Chemistry 60 (13), 5834-5856, 2017
262017
Role of inflammation in pathophysiology of colonic disease: an update
NA Nasef, S Mehta
International journal of molecular sciences 21 (13), 4748, 2020
242020
Anti-Inflammatory Activity of Fruit Fractions in Vitro, Mediated through Toll-Like Receptor 4 and 2 in the Context of Inflammatory Bowel Disease
NA Nasef, S Mehta, P Murray, G Marlow, LR Ferguson
Nutrients 6 (11), 5265-5279, 2014
232014
Adaptive homeostasis and the p53 isoform network
S Mehta, H Campbell, CJ Drummond, K Li, K Murray, T Slatter, ...
EMBO reports 22 (12), e53085, 2021
212021
Dephosphorylation of YB-1 is Required for Nuclear Localisation During G2 Phase of the Cell Cycle
S Mehta, C McKinney, M Algie, CS Verma, S Kannan, R Harfoot, ...
Cancers 12 (2), 315, 2020
212020
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation
M Kazantseva, S Mehta, RA Eiholzer, N Hung, A Wiles, TL Slatter, ...
Mammalian genome 29, 831-842, 2018
192018
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes
SY Mehta, BC Morten, J Antony, L Henderson, A Lasham, H Campbell, ...
Oncotarget 9 (49), 29146, 2018
182018
Extracts of Feijoa inhibit Toll-like receptor 2 signaling and Activate Autophagy Implicating a role in dietary control of IBD
NA Nasef, S Mehta, P Powell, G Marlow, T Wileman, LR Ferguson
PloS one 10 (6), e0130910, 2015
172015
Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells
N Arsic, T Slatter, G Gadea, E Villain, A Fournet, M Kazantseva, ...
Nature communications 12 (1), 5463, 2021
162021
The system can't perform the operation now. Try again later.
Articles 1–20